These preliminary findings indicate that oral treatment with 600 mg of TA t.i.d. for 3 weeks may improve symptoms and deficits resulting from polyneuropathy in Type 2 diabetic patients, without causing significant adverse reactions.
No takes yet. Share an insight, caveat, or question.
Ruhnau et al. (1999) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: